Colon

Artículos de Interés

Directrices mundiales de la Organización Mundial de Gastroenterología sobre el Manejo de la estrongiloidiasis

Ver PDF

Systematic review: Histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative. 
R.V.Bryant, S.Winer, Travis S. and R.H.Riddell.

Optical diagnosis of colorectal polyps with Blue Light Imaging using a new international classification. 
Sharmila Subramaniam et al.

Ileocolitis de Crohn refractaria secundaria a colitis amebiana: un caso clínico. 
M.D. Martín Arranza y L. Guerra Pastrian.

Interest of Anorectal Manometry During Long-term Follow-up of Patients Operated on for Hirschsprung’s Disease. 
Viet Q Tran et al.

Increased Tone of the Human Colon Muscle by Bisacodyl In Vitro. 
Yang Won Min et al.

Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350. 
Hye-kyung Jung and Nicholas J Talley.

Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. 
Kyung Ho Song et al.

Dysregulation of GABAergic Signalling Contributes in the Pathogenesis of Diarrhea-predominant Irritable Bowel Syndrome. 
Surbhi Aggarwal, Vineet Ahuja, and Jaishree Paul.

Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists. 
Adrienne Lenhart et al.

Connecting Our Gut Feeling and How Our Gut Feels: The Role of Well-being Attributes in Irritable Bowel Syndrome. 
Ashkan Farhadi, Dwaine Banton, and Laurie Keefer.

Increased Postprandial Colonic Motility and Autonomic Nervous System Activity in Patients With Irritable Bowel Syndrome: A Prospective Study. 
Yukari Tanaka et al.

Expression of Toll-like Receptors, Pro-, and Antiinflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis . 
Ratnakar Shukla et al.

Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation . 
Eric D Shah et al.

Citomegalovirus y enfermedad inflamatoria intestinal: una relación compleja. 
Rodríguez-Goncer et al

Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology . 
Kathryn Oakland et al.

Algoritmos de tratamiento de la colitis ulcerosa desde una experiencia localUlcerative colitis treatment algorithm . 
Carolina Figueroa et al.

Piezo2: A Candidate Biomarker for Visceral Hypersensitivity in Irritable Bowel Syndrome? . 
Tao Bai et al.

Biomarkers of Irritable Bowel Syndrome. 
Jae Hak Kim, Eugenia Lin, and Mark Pimente.

Chronic Intestinal Pseudo-obstruction: Clinical and Manometric Characteristics in the Chilean Population. 
Edith Pérez de Arce et al.

Exploratory Analysis of Plasma Neurotensin as a Novel Biomarker for Early Detection of Colorectal Polyp and Cancer Shengyang. 
Shengyang Qiu et al.

Use of Phosphodiesterase 5 Inhibitors Associates With Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms. 
Wuqing Huang et al.

Actualización sobre los medicamentos biocomparables en la enfermedad inflamatoria intestinal: posición y recomendación en México. 
A. Mayoral-Zavala et al.

Schwannoma of the colon and rectum: a systematic literature review. 
Ali Bohlok et al.

Inpatient Management of Acute Severe Ulcerative Colitis. 
David I Fudman et al.

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
 Magdy El-Salhy et al.